Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

TRANSPARENCY-RX CORP.

Filed by ARENTFOX SCHIFF LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
0090e64b-e21f-4f40-8c91-8e0123ab29e6
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices S. 891 (Bipartisan Health Care Act), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices

Literal federal measure citations: S. 891

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.